Document ID: chunk:federal_register_of_legislation:F2021L00603:reg:9:p3
Version: federal_register_of_legislation:F2021L00603
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 9300–11067

or hypopharynx;
(11)      having infection with human immunodeficiency virus before the clinical onset of malignant neoplasm of the oral cavity, oropharynx or hypopharynx;
(12)      taking an immunosuppressive drug for organ or tissue transplantation at least 3 years before the clinical onset of malignant neoplasm of the oral cavity, oropharynx or hypopharynx.
Note: organ or tissue transplantation is defined in the Schedule 1 - Dictionary.
(13)      being obese for at least 5 years within the 20 years before the clinical onset of malignant neoplasm of the oral cavity, oropharynx or hypopharynx;
Note: being obese is defined in the Schedule 1 - Dictionary.
(14)      an inability to consume an average of at least 100 grams per day of any combination of fruits and vegetables, for a period of at least 5 consecutive years within the 20 years before the clinical onset of malignant neoplasm of the oral cavity, oropharynx or hypopharynx;
(15)      having periodontitis for at least 5 years within the 20 years before the clinical onset of malignant neoplasm of the oral cavity, oropharynx or hypopharynx;
(16)      for malignant neoplasm of the oral cavity only, having an oral lesion at the affected site, from the specified list of oral lesions, for at least the 1 year before the clinical onset of malignant neoplasm of the oral cavity;
Note: specified list of oral lesions is defined in the Schedule 1 - Dictionary.
(17)      for malignant neoplasm of the oral cavity only, having an oral lesion caused by systemic lupus erythematosus for at least the 1 year before the clinical onset of malignant neoplasm of the oral cavity;
(18)      inability to obtain appropriate clinical management for malignant neoplasm of the oral cavity, oropharynx or hypopharynx.